Cellebrite Genesis Enterprise Expansion Expands Global Market Access
Global enterprise availability and new capabilities suggest higher future ARR and revenue visibility; near-term uplift driven by new markets (AU/UK) and EU rollout.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Global enterprise availability and new capabilities suggest higher future ARR and revenue visibility; near-term uplift driven by new markets (AU/UK) and EU rollout.
What happened, with direct paths to the underlying reporting
Cellebrite announced Genesis is now generally available for enterprise organizations, with availability in Australia and the United Kingdom and EU rollout expected soon. The move builds on a June 2026 public-safety launch and comes amid meaningful global user growth and ongoing enterprise adoption, supported by the new Deep Investigator capability that probes deeper mobile data to accelerate investigations.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.